← Back to MiMOUD

Sources

The Toxic Cost of the Urine Cup — Drug Testing in MOUD

1. ASAM / American College of Medical Toxicology — Draft Clinical Consensus Statement on Drug Testing in Substance Use Disorder Treatment (2026 public-comment draft).
   Central source for patient-specific testing, limits of universal testing, presumptive vs. confirmatory testing, costs, and potential harms — asam.org/quality-care/clinical-guidelines/drug-testing
2. ASAM — Appropriate Use of Drug Testing in Clinical Addiction Medicine (standing 2017 consensus guidance).
   The established guidance while the 2026 update remains a draft — asam.org/quality-care/clinical-guidelines/drug-testing
3. ASAM / AAAP — Clinical Practice Guideline on the Management of Stimulant Use Disorder.
   Role of contingency management and treatment of methamphetamine/stimulant-use disorder — asam.org/quality-care/clinical-guidelines/stimulant-use-disorders
4. SAMHSA — TIP 63: Medications for Opioid Use Disorder, plus current buprenorphine/MAT Act guidance.
   Medication-first principle: behavioral services should support, not obstruct, access to buprenorphine — samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder